J. Dibrino

发表

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides.

A. R. English, A. Nagel, J. Bordner, 1988, The Journal of antibiotics.

trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor.

B. Dominy, M. Ramchandani, M. Conklyn, 1998, Bioorganic & medicinal chemistry letters.

New bicyclic cannabinoid receptor-1 (CB1-R) antagonists.

D. Scott, P. Iredale, S. Sakya, 2006, Bioorganic & medicinal chemistry letters.

Investigation of the effects of synthetic, non-cytotoxic immunophilin inhibitors on MDR

S. Kajiji, P. Dorff, J. Dibrino, 1994 .

Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.

Jacquelyn L. Klug-McLeod, Daniel P. Walker, David A. Price, 2012, Bioorganic & medicinal chemistry letters.

Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin.

S. Toler, B. Lefker, J. A. Ragan, 2003, Bioorganic & medicinal chemistry.

Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity

Arun K. Ghosh, S. Caron, J. A. Ragan, 2009 .

Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity.

T. Maurer, D. Hargrove, D. Tess, 2007, Bioorganic & medicinal chemistry letters.

Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.

Margaret S. Landis, D. Scott, P. Iredale, 2009, Journal of medicinal chemistry.

Design and synthesis of novel FKBP inhibitors.

R. Williams, P. Dorff, J. Dibrino, 1992, Journal of medicinal chemistry.